Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
SAP sales software pitch gets high marks, execution now key

2018-07-18 reuters
FRANKFURT (Reuters) - Germany-based SAP’s late push into fast-growing sales and marketing software has won Europe’s most valuable technology company plaudits from industry analysts. Now it must show it can deliver.
FORR

0
Newgen Demonstrates Technologies to Drive Digital Transformation at its Customer Conference 2018, Orlando

2018-07-18 globenewswire
McLean, VA, July 18, 2018 (GLOBE NEWSWIRE) -- Newgen Software Inc., a provider of Business Process Management (BPM), Enterprise Content Management (ECM) and Customer Communication Management (CCM) platforms, today announced that it successfully hosted its Customer Conference at Marriott World Center, Orlando, FL on June 21 and 22, 2018. The conference brought together industry leaders, influencers, and analysts from leading organizations across the US, Canada, Caribbean and South America.
FORR

0
Amazon upbeat about Prime Day, despite early glitches

2018-07-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
FORR

0
FORR / Forrester Research, Inc. 8-K (Current Report)

2018-07-10 sec.gov
8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORR

0
CACI vs. FORR: Which Stock Should Value Investors Buy Now?

2018-07-09 zacks
Investors interested in Computer - Services stocks are likely familiar with CACI International (CACI - Free Report) and Forrester Research (FORR - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
FORR CACU CACI

2
Carbon Black Named a “Leader” in Endpoint Detection and Response (EDR) by Independent Research Firm

2018-07-05 globenewswire
WALTHAM, Mass., July 05, 2018 (GLOBE NEWSWIRE) -- Carbon Black (NASDAQ:CBLK), a leader in next-generation endpoint security, today announced the company was named a “Leader” in the Forrester Research Inc. report, The Forrester Wave™: Endpoint Detection And Response, Q3 2018, receiving the highest possible scores in the product vision, market approach, and number of customers criteria.
FORR CBLK

35
Google tackles Facebook in India with hyper-local social network

2018-06-25 livemint
Bangalore: A Mumbai train commuter who witnessed an accident earlier this month, turned to his smartphone to ask neighbours how to help a bleeding victim. Responses poured in instantaneously. Take him to the station master at the next stop; ask the ticket collector for first aid; call 138 for emergency help and so on. Not long after, the commuter posted a happy ending: the injured party had received medical attention.
FB FORR

1
As Facebook ages, teens look elsewhere to connect

2018-06-24 technology.inquirer.net
SAN FRANCISCO, United States – Manon, 17, has a Facebook account but to connect with her friends she turns to other social networks like Instagram or Snapchat.
FORR

1
As Facebook ages, teens look elsewhere to connect

2018-06-24 yahoo
San Francisco (AFP) - Manon, 17, has a Facebook account but to connect with her friends she turns to other social networks like Instagram or Snapchat.
FORR

1
FORR / Forrester Research, Inc. S-8

2018-06-22 sec.gov
S-8 As filed with the Securities and Exchange Commission on June 22, 2018 Registration No. 333-
FORR

1
FORR / Forrester Research, Inc. S-8 POS

2018-06-22 sec.gov
S-8 POS As filed with the Securities and Exchange Commission on June 22, 2018 Registration No. 333-99751
FORR

1
FORR / Forrester Research, Inc. S-8 POS

2018-06-22 sec.gov
S-8 POS As filed with the Securities and Exchange Commission on June 22, 2018 Registration No. 333-96393
FORR

1
FORR / Forrester Research, Inc. S-8 POS

2018-06-22 sec.gov
S-8 POS As filed with the Securities and Exchange Commission on June 22, 2018 Registration No. 333-38626
FORR

1
FORR / Forrester Research, Inc. S-8 POS

2018-06-22 sec.gov
S-8 POS As filed with the Securities and Exchange Commission on June 22, 2018 Registration No. 333-22749
FORR

13
Tesla to close a dozen solar facilities in 9 states: Documents

2018-06-22 cnbc
Electric car maker Tesla's move last week to cut 9 percent of its workforce will sharply downsize the residential solar business it bought two years ago in a controversial $2.6 billion deal, according to three internal company documents and seven current and former Tesla solar employees.
HD FORR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to FORR / Forrester Research, Inc. on message board site Silicon Investor.

Forrester Research a scam? FORR
CUSIP: 346563109